Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Testosterone therapy in men" and "Society guideline links: Male sexual dysfunction".)
International
●Endocrine Society (ES): Clinical practice guideline on testosterone therapy in men with hypogonadism (2018)
Canada
●Choosing Wisely Canada: Don't routinely perform sperm DNA fragmentation testing (updated 2019)
●Choosing Wisely Canada: Don't order serum testosterone in men without symptoms of hypogonadism (updated 2017)
United States
●American Society for Reproductive Medicine (ASRM): Ethics committee opinions and webinars
●ASRM: Evidence-based treatments for couples with unexplained infertility – A guideline (2020)
●ASRM: The management of obstructive azoospermia – A committee opinion (2019)
●ASRM: Evaluation of the azoospermic male – A committee opinion (2018)
●ASRM: Management of nonobstructive azoospermia – A committee opinion (2018)
●ASRM: Smoking and infertility – A committee opinion (2018)
●ASRM: Diagnostic evaluation of the infertile male – A committee opinion (2015)
●ASRM: Obesity and reproduction – A committee opinion (2015)
●US Food and Drug Administration (FDA): Testosterone information (updated 2015)
●ASRM: The clinical utility of sperm DNA integrity testing – A guideline (2013)
●Choosing Wisely: Don't perform a postcoital test (PCT) for the evaluation of infertility (2013)
●Choosing Wisely: Don't perform immunological testing as part of the routine infertility evaluation (2013)
Europe
●European Academy of Andrology (EAA): Guideline – Management of oligo-astheno-teratozoospermia (2018)
●European Association of Urology (EAU): Guidelines on sexual and reproductive health (2018)
●European Menopause and Andropause Society (EMAS): Position statement on fertility preservation (2014)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Clinical guideline on fertility problems – Assessment and treatment (2013, updated 2017)
●NICE: Quality standard on fertility problems (2014)
Australia-New Zealand
●ESA: Position statement on male hypogonadism (part 2) – Treatment and therapeutic considerations (2016)
Japan